Section 9023(e) of the Affordable Care Act provides that taxpayers may receive grants in lieu of the Qualified Therapeutic Discovery Project Credit.
The credit/grant is a tax benefit targeted to therapeutic discovery projects that show a reasonable potential to: Result in new therapies to treat
areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions; Reduce the long-term growth of health care costs in the United States; or Significantly advance the goal of curing cancer within 30 years.
Allocation of the credit/grant will also take into consideration which projects show the greatest potential to create and sustain high-quality, high-paying U.S.
jobs and to advance U.S.
competitiveness in life, biological and medical sciences.